Status:
UNKNOWN
Outcomes Data of Adipose Stem Cells to Treat Parkinson's Disease
Lead Sponsor:
StemGenex
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on the quality o...
Eligibility Criteria
Inclusion
- Subjects scheduled for a stem cell/SVF treatment
- Subjects diagnosed with idiopathic Parkinson's disease
- Subjects ages 18 years and older
- Subjects willing and able to sign informed consent
- Subjects willing and able to perform follow up interviews and surveys
Exclusion
- Subjects with additional major health diagnoses
- Subjects that are pregnant or breastfeeding
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT02184546
Start Date
July 1 2014
End Date
July 1 2019
Last Update
August 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
StemGenex
San Diego, California, United States, 92121